Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.

[1]  D. Rhee,et al.  Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide. , 2005, Biologicals : journal of the International Association of Biological Standardization.

[2]  G. Cole,et al.  Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection. , 2005, Vaccine.

[3]  M. Kataoka,et al.  Endotoxin content in Haemophilus influenzae type b vaccine. , 2004, Japanese journal of infectious diseases.

[4]  G. Cole,et al.  A Recombinant β-1,3-Glucanosyltransferase Homolog of Coccidioides posadasii Protects Mice against Coccidioidomycosis , 2003, Infection and Immunity.

[5]  T. Liang,et al.  Hepatitis C virus–like particles combined with novel adjuvant systems enhance virus‐specific immune responses , 2003, Hepatology.

[6]  Suzanne M Johnson,et al.  In Vitro Whole-Blood Analysis of Cellular Immunity in Patients with Active Coccidioidomycosis by Using the Antigen Preparation T27K , 2002, Clinical and Vaccine Immunology.

[7]  J. Galgiani,et al.  Localization within a Proline-Rich Antigen (Ag2/PRA) of Protective Antigenicity against Infection with Coccidioides immitis in Mice , 2002, Infection and Immunity.

[8]  D. Magee,et al.  Role of Signal Sequence in Vaccine-Induced Protection against Experimental Coccidioidomycosis , 2002, Infection and Immunity.

[9]  U. Reichard,et al.  A Parasitic Phase-Specific Adhesin of Coccidioides immitis Contributes to the Virulence of This Respiratory Fungal Pathogen , 2002, Infection and Immunity.

[10]  J. Galgiani,et al.  Protection of Mice against Coccidioides immitis Intranasal Infection by Vaccination with Recombinant Antigen 2/PRA , 2002, Infection and Immunity.

[11]  D. Geier,et al.  Clinical Implications of Endotoxin Concentrations in Vaccines , 2002, The Annals of pharmacotherapy.

[12]  T. White,et al.  Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis , 2002, Mycologia.

[13]  G. Cole,et al.  Recombinant Urease and Urease DNA ofCoccidioides immitis Elicit an Immunoprotective Response against Coccidioidomycosis in Mice , 2001, Infection and Immunity.

[14]  G. Cole,et al.  Cloning and Expression of the Gene Which Encodes a Tube Precipitin Antigen and Wall-Associated β-Glucosidase ofCoccidioides immitis , 2001, Infection and Immunity.

[15]  D. Pappagianis,et al.  Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities. , 2001, Fungal genetics and biology : FG & B.

[16]  Paul L. Williams,et al.  Practice Guidelines for the Treatment of Coccidioidomycosis , 2000 .

[17]  J. J. Yu,et al.  Sequence, expression and functional analysis of the Coccidioides immitis ODC (ornithine decarboxylase) gene. , 2000, Gene.

[18]  D. Magee,et al.  Coadministration of Interleukin 12 Expression Vector with Antigen 2 cDNA Enhances Induction of Protective Immunity againstCoccidioides immitis , 1999, Infection and Immunity.

[19]  J. Galgiani,et al.  Resistance to Coccidioides immitis in Mice after Immunization with Recombinant Protein or a DNA Vaccine of a Proline-Rich Antigen , 1999, Infection and Immunity.

[20]  D. Magee,et al.  Genetic Vaccination against Coccidioides immitis: Comparison of Vaccine Efficacy of Recombinant Antigen 2 and Antigen 2 cDNA , 1999, Infection and Immunity.

[21]  N. Ampel,et al.  Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Galgiani,et al.  Evaluation of the Proline-Rich Antigen ofCoccidioides immitis as a Vaccine Candidate in Mice , 1998, Infection and Immunity.

[23]  Suzanne M Johnson,et al.  Protection against Lethal Murine Coccidioidomycosis by a Soluble Vaccine from Spherules , 1998, Infection and Immunity.

[24]  T. Kirkland,et al.  Immunogenicity of a 48-Kilodalton Recombinant T-Cell-Reactive Protein of Coccidioides immitis , 1998, Infection and Immunity.

[25]  K. Jansen,et al.  Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast. , 1997, The Journal of infectious diseases.

[26]  T. Kirkland,et al.  Isolation and characterization of the urease gene (URE) from the pathogenic fungus Coccidioides immitis. , 1997, Gene.

[27]  D. Magee,et al.  Coccidioides immitis antigen 2: analysis of gene and protein. , 1996, Gene.

[28]  N. Ampel,et al.  Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. , 1996, The Journal of infectious diseases.

[29]  J. H. Law,et al.  Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential. , 1996, Biochemical and biophysical research communications.

[30]  G. Cole,et al.  Molecular and biochemical characterization of a Coccidioides immitis-specific antigen , 1995, Infection and immunity.

[31]  B. Zimmer,et al.  Serology of coccidioidomycosis , 1990, Clinical Microbiology Reviews.

[32]  A. Garg,et al.  Evaluation of commercial reagents to identify the exoantigens of Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma species cultures. , 1984, American journal of clinical pathology.

[33]  B. W. Brown,et al.  Immunologic responsiveness and safety associated with the Coccidioides immitis spherule vaccine in volunteers of white, black, and Filipino ancestry. , 1984, American journal of epidemiology.

[34]  P. Standard,et al.  Evaluation of a commercial exoantigen test system for the rapid identification of systemic fungal pathogens. , 1983, American journal of clinical pathology.

[35]  G. Land,et al.  Evaluation of the exoantigen test for identification of Histoplasma species and Coccidioides immitis cultures , 1980, Journal of clinical microbiology.

[36]  S. Sun,et al.  Specificity of exoantigens for identifying cultures of Coccidioides immitis , 1978, Journal of clinical microbiology.

[37]  L. Kaufman,et al.  Improved version of the exoantigen test for identification of Coccidioides immitis and Histoplasma capsulatum cultures , 1978, Journal of clinical microbiology.

[38]  Y. Kong,et al.  IMMUNIZATION OF MICE TO COCCIDIOIDES IMMITIS: DOSE, REGIMEN AND SPHERULATION STAGE OF KILLED SPHERULE VACCINES. , 1965, Journal of immunology.

[39]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[40]  C. Smith,et al.  Pattern of 39,500 serologic tests in coccidioidomycosis. , 1956, Journal of the American Medical Association.

[41]  K. Blennow,et al.  Identification of proteins in a human pleural exudate using two‐dimensional preparative liquid‐phase electrophoresis and matrix‐assisted laser desorption/ionization mass spectrometry , 1999, Electrophoresis.

[42]  M. Rosolowsky,et al.  Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. , 1995, Vaccine.